GOLM1 and metabolic dysfunction-associated steatohepatitis: The mean serum GP73 concentrations of MASLD and MASH patients were 30 ± 12 ng/mL and 32 ± 12 ng/mL, respectively, and were significantly higher than that of the control group (19 ± 30 ng/mL) (p < 0.05) (Table 3).